HomeHEPA • NASDAQ
Hepion Pharmaceuticals Inc
add
$0.49
12.82%
Pre-market:(5.15%)+0.025
$0.51
Closed: Apr 2, 12:30:48 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.46M | -58.20% |
Net income | -4.87M | 53.78% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.46M | 58.12% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.50M | -92.24% |
Total assets | 3.72M | -85.14% |
Total liabilities | 4.12M | -53.40% |
Total equity | -406.69K | — |
Shares outstanding | 139.17K | — |
Price to book | -0.03 | — |
Return on assets | -229.21% | — |
Return on capital | -402.88% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.87M | 53.78% |
Cash from operations | -2.52M | 77.59% |
Cash from investing | -600.00K | -23,337.80% |
Cash from financing | 2.50M | — |
Net change in cash | -617.94K | 94.50% |
Free cash flow | -1.57M | 78.87% |
Previous close
$0.43
Day range
$0.43 - $0.99
Year range
$0.40 - $145.00
Market cap
526.11K USD
Avg Volume
1.45M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Website
Employees
22
